What effect does a clotting factor deficiency typically have on aPTT results?

What effect does a clotting factor deficiency typically have on aPTT results?

• A. A decrease in aPTT
• B. No effect on aPTT
• C. A prolongation of aPTT
• D. A prolongation of PT

Answer: (C)

A clotting factor deficiency typically leads to a prolongation of activated partial thromboplastin time (aPTT) results. This is because aPTT measures the time it takes for blood to clot through the intrinsic and common coagulation pathways, which involve factors such as factor VIII, IX, XI, and XII. When there is a deficiency in one or more of these clotting factors, the clotting process is delayed, resulting in an increased aPTT value. This phenomenon is particularly significant in conditions like hemophilia, where there is a deficiency of factor VIII or IX, leading to prolonged aPTT due to the specific impact on the intrinsic pathway. Thus, the presence of a clotting factor deficiency disrupts the normal clotting cascade, extending the time it takes for the blood to clot, which is reflected in the aPTT measurements.

A clotting factor deficiency typically leads to a prolongation of activated partial thromboplastin time (aPTT) results. This is because aPTT measures the time it takes for blood to clot through the intrinsic and common coagulation pathways, which involve factors such as factor VIII, IX, XI, and XII. When there is a deficiency in one or more of these clotting factors, the clotting process is delayed, resulting in an increased aPTT value.

This phenomenon is particularly significant in conditions like hemophilia, where there is a deficiency of factor VIII or IX, leading to prolonged aPTT due to the specific impact on the intrinsic pathway. Thus, the presence of a clotting factor deficiency disrupts the normal clotting cascade, extending the time it takes for the blood to clot, which is reflected in the aPTT measurements.